Original Article: The Medical News http://bit.ly/2vtn9T2
Immunotherapy drug found to be effective in patients with advanced Merkel cell carcinoma
A multi-center phase II clinical trial investigating pembrolizumab as a first-line and programmed cell death-1 therapy in patients with advanced Merkel cell carcinoma reports lasting tumor control, generally manageable side effects and improved overall survival.
Original Article: The Medical News http://bit.ly/2vtn9T2
>>Hollywood's Exotic Secret For Healthy Weight Loss
Original Article: The Medical News http://bit.ly/2vtn9T2
Subscribe to:
Post Comments (Atom)
0 Response to "Immunotherapy drug found to be effective in patients with advanced Merkel cell carcinoma"
Post a Comment